Authors: GANDARA DR LARA P CADMAN T LAU D UHRICH M TURRELL C MORGAN R DIMERY I EDELMAN M PEREZ EA SYNOLD T DOROSHOW J MUGGIA F DEGREGORIO M

Citation: Dr. Gandara et al., HIGH-DOSE TOREMIFENE AS A CISPLATIN MODULATOR - TARGETED PLASMA-LEVELS ARE ACHIEVABLE CLINICALLY, Journal of investigative medicine, 46(1), 1998, pp. 148-148

Authors: HOWELL A OSBORNE CK MORRIS CQ DIMERY I

Citation: A. Howell et al., BREAST-CANCER CLINICAL-TRIALS WITH FASLODEX - A NEW CLASS OF ANTIESTROGEN, European journal of cancer, 34, 1998, pp. 74-74

Authors: DEVORE R JOHNSON D CRAWFORD J DIMERY I ECKARDT J ECKHARDT SG

Citation: R. Devore et al., AN OVERVIEW OF PHASE-II TRIAL RESULTS - IRINOTECAN PLUS CISPLATIN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Oncology, 12(8), 1998, pp. 79-83

Authors: GARCIA AA PARIMOO D DIMERY I ROGERS M JEFFERS S MUGGIA FM

Citation: Aa. Garcia et al., TOLERANCE OF PACLITAXEL 3-HOUR INFUSION WITH AND WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR ON A BIWEEKLY SCHEDULE, Seminars in oncology, 24(6), 1997, pp. 62-66